Company Filing History:
1 out of 152 
1 out of 1,461 
1 out of 3,697 
Years Active: 1999-2003
Title: The Innovative Contributions of Omar L Sprockel
Introduction
Omar L Sprockel is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis B virus infections. With a total of 3 patents to his name, Sprockel's work has had a meaningful impact on medical formulations.
Latest Patents
One of Sprockel's latest patents is focused on a low dose entecavir formulation. This innovative composition is designed for daily administration to treat hepatitis B virus infections and co-infections. The formulation allows for the inclusion of other pharmaceutically active substances, enhancing its effectiveness in treating patients. Another significant patent involves pharmaceutical compositions containing irbesartan. This formulation provides tablets with a high relative amount of active agent, ensuring excellent wetting and disintegration properties.
Career Highlights
Throughout his career, Omar L Sprockel has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Sanofi. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical compositions.
Collaborations
Sprockel has collaborated with several professionals in his field, including Cathy C Ku and Beth A Lang. These collaborations have likely enriched his work and contributed to the success of his inventions.
Conclusion
Omar L Sprockel's innovative contributions to pharmaceutical formulations demonstrate his commitment to improving treatments for hepatitis B virus infections. His patents reflect a dedication to advancing medical science and enhancing patient care.